|
2025
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases,... |
|
|
G/S
|
Pharmaceutical and biological preparations for human use. |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metab... |
|
2024
|
Invention
|
Substituted phenyl oxazolone compounds.
Disclosed are compounds of Formula (I):
Disclosed are ... |
|
|
Invention
|
Gspt1 compounds and methods of use of the novel compounds.
Provided herein are compounds having ... |
|
|
Invention
|
Antibodies binding to vista at acidic ph.
The present application relates to antibodies specific... |
|
|
Invention
|
Aminotriazolopyridines as kinase inhibitors.
Compounds having formula (I)-(IX), and enantiomers,... |
|
|
Invention
|
Gspt1-degrading compounds, anti-cd33 antibodies and antibody-drug conjugates and uses thereof. Th... |
|
|
Invention
|
Framework for document layout and information extraction.
A method includes receiving a file in ... |
|
|
Invention
|
Gspt1 compounds and methods of use of the compounds. Provided herein are compounds of Formula I:,... |
|
|
Invention
|
Methods for predicting responsiveness of lymphoma to drug and methods for treating lymphoma. Prov... |
|
|
Invention
|
Crystalline forms of a par4 inhibitor.
The present invention relates to co-crystals of the compo... |
|
|
Invention
|
Substituted azetidinyl oxoisoindolinyl piperidine-2,6-dione compounds. Disclosed are compounds of... |
|
|
Invention
|
A method of treating lupus. Disclosed is a method of treating a disease, comprising administering... |
|
|
Invention
|
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-mor... |
|
|
Invention
|
Triazolopyridinyl ether linked compounds as kinase inhibitors. Compounds having formula (I), and ... |
|
|
Invention
|
Piperidine substituted pyrazolopyrimidine derivatives as inhibitors of sgk1. The present inventio... |
|
|
Invention
|
Triazolopyridinyl compounds as kinase inhibitors. Compounds having formula (I), and enantiomers, ... |
|
|
Invention
|
Antibodies against tim3 and uses thereof.
Provided herein are antibodies, or antigen binding por... |
|
|
Invention
|
Medical injector for on-body mounting with flow detecting. In one aspect, a medical injector is p... |
|
|
Invention
|
Modulators of bcl6 for use in a method of treating a cancer or an autoimmune disease. Provided he... |
|
|
Invention
|
Substituted oxoisoindolinyl piperidine-2,6-dione compounds. 1233, m, and n are defined herein. Al... |
|
|
Invention
|
Substituted oxoisoindolinyl piperidine-2,6-dione compounds.
Disclosed are compounds of Formula (... |
|
|
Invention
|
Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonists.
The present invention provides ... |
|
|
Invention
|
Substituted phenyl oxooxazolyl piperidine dione compounds. Disclosed are compounds of Formula (I)... |
|
|
Invention
|
Protein recovery.
The disclosure provides a novel flush method using a recovery flush technique ... |
|
|
Invention
|
Methods of treating tumor.
The disclosure provides a method for treating a subject afflicted wit... |
|
|
Invention
|
Triazolopyridinyl compounds as kinase inhibitors.
Compounds having formula (I), and enantiomers,... |
|
|
Invention
|
Co-crystals of nitroxyl donating compounds. NN-hydroxysulfonamide compounds, pharmaceutical compo... |
|
|
Invention
|
Compositions comprising antibodies that bind bcma and cd3 and methods of treatment. Provided here... |
|
|
Invention
|
Ceramic hydroxyapatite chromatography flow through method. The present disclosure is directed met... |
|
|
Invention
|
Assay to determine in vivo receptor occupancy.
The present invention relates to assays for monit... |
|
|
Invention
|
Methods of treating colorectal cancer.
This disclosure provides methods for treating a tumor der... |
|
|
Invention
|
Anti-nkg2a antibodies and uses thereof.
The present disclosure provides isolated monoclonal anti... |
|
|
Invention
|
Methods of assessing citrullination and activity of pad4 modulators. The present application rela... |
|
|
Invention
|
Heterocyclic pad4 inhibitors. The disclosure generally relates to compounds of Formula I, which a... |
|
|
Invention
|
Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer age... |
|
|
Invention
|
Kras inhibitors. The present disclosure provides KRAS inhibitors. Methods of treating cancers usi... |
|
|
Invention
|
Substituted oxoisoindolinyl piperidine-2,6-dione compound as anticancer agent. Disclosed is a com... |
|
|
Invention
|
Lag-3 combination therapy for the treatment of cancer.
The invention provides a method of treati... |
|
|
Invention
|
Treatment of lag-3 positive tumors.
The invention provides a method of treating a tumor in a hum... |
|
|
Invention
|
Radioligands for imaging the lpa1 receptor.
The present invention relates to radiolabeled LPA1 r... |
|
2022
|
Invention
|
Systems and methods of selecting compounds that induce conformational changes in mutant cereblon.... |
|
|
Invention
|
Detergent for viral inactivation.
The present disclosure provides compositions and methods of in... |
|
|
Invention
|
Naphthalene and quinoline analogs as rxfp1 agonists.
The disclosure relates to compounds of Form... |
|
|
Invention
|
Benzothiazole, benzoisoxazole, and benzodioxole analogs as rxfp1 receptor agonists.
The disclosu... |
|
|
Invention
|
Bicyclo [3.2.0] heptane bis(amide) rxfp1 agonists.
The disclosure relates to compounds of Formul... |
|
|
Invention
|
Rxfp1 agonists.
The disclosure relates to compounds of Formula (I), which arm RXFP1 receptor ago... |
|
|
Invention
|
Milvexian for prevention and treatment of thromboembolic disorders.
The factor Xia inhibitor mil... |
|
|
Invention
|
Cell culture methods for producing therapeutic proteins.
The present invention generally relates... |
|
|
Invention
|
Cyclic peptide immunomodulators.
The present disclosure provides novel macrocyclic peptides whic... |
|
|
Invention
|
Substituted heterocyclic compounds.
There are disclosed compounds of the following formula (I): ... |
